Corticosteroids for Systemic Use

Phase 3Small molecule

Corticosteroids for Systemic Use is one of 6 small molecule programs targeting Giant Cell Arteritis. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Giant Cell ArteritisRecruiting

Giant Cell ArteritisPhase 3

Recruiting

Competition

Competitive Landscape

7 competitors in Giant Cell Arteritis

#DrugCompanyPhaseTrials

Actemra

CCelltrion

Approved

9 2

Orencia

Bristol-Myers Squibb

Phase 3

3 3

Trexall

Jazz Pharmaceuticals

Phase 3

3 4

Tracleer

Johnson & Johnson

Phase 2

1 5

Prednisone Treatment

CCentre Hospitalier Universitaire Dijon

Phase 3

2 6

Corticosteroids for Systemic Use

UUniversity Hospital, Caen

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2029

Phase 3Recruiting

Giant Cell Arteritis

NCT04012905

Clinical

Trials by Indication[1]

Giant Cell Arteritis1 trial

A Randomized, Controled, Open Label Trial: Comparison Between Two Standardized Corticosteroids Tapering, Respectively Short (North American) and Long (European), in Giant Cell Arteritis

Recruiting·UUniversity Hospital, Caen·Phase 3·NCT04012905·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Corticosteroids for Systemic Use. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Corticosteroids for Systemic Use compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Corticosteroids for Systemic Use. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Caen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity Hospital, Caen

Corticosteroids for Systemic Use

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2029

Trials by Indication[1]

Giant Cell Arteritis1 trial

References

Drug Info

Quick Facts

Related News